Baxter International (BAX) has drawn fresh attention after reporting first quarter 2026 results that topped Wall Street expectations on revenue and adjusted earnings, while reaffirming full year ...

Baxter International reported first-quarter 2026 results with sales of US$2,701 million, a net loss of US$15 million, and a diluted loss per share of US$0.03, while reaffirming full-year guidance for ...

Baxter International Inc. BAX reported better-than-expected first-quarter earnings on Thursday and reaffirmed its fiscal 2026 ...

Healthcare company Baxter International (NYSE:BAX) reported in Q1 CY2026, with sales up 2.9% year on year to $2.70 billion.

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter (BAX) stock jumps as the company exceeds Street forecasts with its Q1 2026 financials thanks to international sales.

Baxter President and CEO Andrew Hider's total compensation for 2025 makes him one of the highest paid CEOs in medtech.

Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting ...

Baxter International (NYSE:BAX) is one of the 10 Best Medical Stocks to Buy Under $30. On April 6, Evercore ISI analyst Vijay ...

Baxter International posted a first-quarter loss on higher expenses and one-off items but the health-care conglomerate's sales growth exceeded Wall Street expectations and it backed 2026 growth ...

Learn more about Baxter International Inc.'s (BAX) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Health Care Equipment & Supplies stock meets your ...